cambridge

Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732

HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being investigated to treat a wide range of solid…

1 week ago

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 12, 2025 16:30 ET  | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics,…

2 weeks ago

Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum

September 12, 2025 07:00 ET  | Source: Cullinan Therapeutics, Inc. CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics,…

2 weeks ago

Zai Lab Announces Approval of TIVDAK for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the Hong Kong Department of Health has…

3 weeks ago

Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell

Celebrates Indian Independence Day by Honoring the US-India Innovation PartnershipCAMBRIDGE, Mass.--(BUSINESS WIRE)--$HIND--Vyome Holdings (Nasdaq: HIND), a clinical-stage healthcare holding company…

1 month ago

Commuting up Mount Snowdon: FLIT M2 Shows What a Single-Speed Folding Ebike Can Do

Thursday 31 July, 2025 FLIT, the Cambridge-based ebike developer, has released a new video showcasing its latest folding ebike, the…

2 months ago

96% of health care executives are “ready and resourced” to use digital health solutions, yet two-thirds say interoperability is “a tough but manageable challenge,” reveals new MIT Technology Review Insights report

CAMBRIDGE, Mass., June 25, 2025 /PRNewswire/ -- A new survey report by MIT Technology Review Insights reveals the best practices for…

3 months ago

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessas Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist

July 04, 2025 03:00 ET  | Source: Nxera Pharma Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma…

3 months ago

ReversingLabs Named to Inc.s 2025 Best Workplaces List

CAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- ReversingLabs, the trusted name in file and software security, today announced it…

3 months ago

Datalign Launches GEOs, an AI-Powered Geographic Expansion Engine for Financial Advisors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Datalign Advisory launched GEOs, an AI-powered geographic expansion engine to help financial advisors identify underserved consumers. GEOs uses…

4 months ago